DaviesTF. The scientific contributions of Martin Surks, MD, MACP: A pioneer in thyroid hormone physiology, subclinical hypothyroidism, and endocrine education. Thyroid, 2022; 32(7):745–749.
2.
McKenzieJM. A thyroid-stimulating life: An interview with Dr. J. Maxwell McKenzie. Thyroid, 2001; 11(11):1035–1042.
3.
DaviesTF. Braverman's Thyroid—An interview with Lewis Braverman. Thyroid, 2005; 15:188–196.
4.
DaviesTF. Growing an interest in autoimmune thyroid disease—An interview with Robert Volpe MD. Endocrinol Metab Clin North Am, 2000; 29(2):431–442.
5.
DaviesTF. The active times of Jerome Hershman, MD: An interview with the Founding Editor of Thyroid About a Life Devoted to the Thyroid Gland (and Other Things). Thyroid, 2021; 31(11):1609–1612.
6.
RitchieDA.Doing Oral History: A Practical Guide. Oxford University Press: Oxford, UK; 2003.
7.
McLachlanSM. The rate of nutrient release from grass and dung following immersion in lake water. Hydrobiologia, 1971; 37:521–530.
8.
McLachlanSM. The physical environment and bottom fauna of a bog lake. Arch Hydrobiol, 1975; 76:198–217.
9.
MacLeodRD, McLachlanSM. Lateral root elongation in Vicia faba L. Changes in mitotic index in the cap, epidermis, cortex, and stele. Protoplasma, 1974; 81(1):111–124.
10.
MacLeodRD, McLachlanSM. Cell expansion during the elongation of lateral roots of Vicia faba L. Ann Bot, 1975; 39:57–69.
11.
McLachlanSM, SmithBR, PetersenVB, et al.Thyroid-stimulating autoantibody production in vitro. Nature, 1977; 270(5636):447–449.
12.
McGregorA, McLachlanS, ClarkF, et al.Thyroglobulin and microsomal autoantibody production by cultures of Hashimoto peripheral blood lymphocytes. Immunology, 1979; 36(1):81–85.
13.
McLachlanSM, SmithBR, HallR. Kinetics of immunoglobulin production by cultured human peripheral blood lymphocytes. J Immunol Methods, 1978; 21(3–4):211–216.
14.
KohlerG, MilsteinC. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 1975; 256(5517):495–497.
15.
McLachlanSM, PeggCA, AthertonMC, et al.TSH receptor antibody synthesis by thyroid lymphocytes. Clin Endocrinol (Oxf), 1986; 24(2):223–230.
16.
McLachlanSM, PeggCA, AthertonMC, et al.The effect of carbimazole on thyroid autoantibody synthesis by thyroid lymphocytes. J Clin Endocrinol Metab, 1985; 60(6):1237–1242.
17.
FawcettPR, McLachlanSM, NicholsonLV, et al.D-Penicillamine-associated myasthenia gravis: Immunological and electrophysiological studies. Muscle Nerve, 1982; 5(4):328–334.
18.
McLachlanSM, NicholsonLV, VenablesG, et al.Acetylcholine receptor antibody synthesis in lymphocyte cultures. J Clin Lab Immunol, 1981; 5(3):137–142.
19.
McLachlanSM, McGregorA, SmithBR, et al.Thyroid-autoantibody synthesis by Hashimoto thyroid lymphocytes. Lancet, 1979; 1(8108):162–163.
20.
McLachlanSM, DickinsonAM, MalcolmA, et al.Thyroid autoantibody synthesis by cultures of thyroid and peripheral blood lymphocytes. I. Lymphocyte markers and response to pokeweed mitogen. Clin Exp Immunol, 1983; 52(1):43–53.
21.
McGregorAM, PetersenMM, McLachlanSM, et al.Carbimazole and the autoimmune response in Graves' disease. N Engl J Med, 1980; 303(6):302–307.
22.
NagayamaY, KaufmanKD, SetoP, et al.Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun, 1989; 165(3):1184–1190.
23.
RapoportB, ChazenbalkGD, JaumeJC, et al.The thyrotropin (TSH) receptor: Interaction with TSH and autoantibodies. Endocr Rev, 1998; 19(6):673–716.
24.
MagnussonRP, ChazenbalkGD, GestautasJ, et al.Molecular cloning of the complementary deoxyribonucleic acid for human thyroid peroxidase. Mol Endocrinol, 1987; 1:856–861.
25.
SetoP, HirayuH, MagnussonRP, et al.Isolation of a cDNA clone for the thyroid microsomal antigen: Homology with the gene for thyroid peroxidase. J Clin Invest, 1987; 80:1205–1208.
26.
ChazenbalkGD, PortolanoS, RussoD, et al.Human organ-specific autoimmune disease: Molecular cloning and expression of an autoantibody gene repertoire for a major autoantigen reveals an antigenic dominant region and restricted immunoglobulin gene usage in the target organ. J Clin Invest, 1993; 92:62–74.
27.
RapoportB, PortolanoS, McLachlanSM. Combinatorial libraries: New insights into human organ-specific autoantibodies. Immunol Today, 1995; 16(1):43–49.
28.
BakerS, MiguelRN, ThomasD, et al.Cryo-electron microscopy structures of human thyroid peroxidase (TPO) in complex with TPO antibodies. J Mol Endocrinol, 2023; 70(3):e220149.
29.
NagayamaY, SaitohO, McLachlanSM, et al.TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm. Clin Exp Immunol, 2004; 138(3):417–422.
30.
McLachlanSM, NagayamaY, RapoportB. Insight into Graves' hyperthyroidism from animal models. Endocr Rev, 2005; 26(6):800–832.
31.
MizutoriY, ChenCR, LatrofaF, et al.Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease. J Clin Endocrinol Metab, 2009; 94(3):927–935.
32.
RapoportB, AlieskyHA, BanuelosB, et al.A unique mouse strain that develops spontaneous, iodine-accelerated, pathogenic antibodies to the human thyrotrophin receptor. J Immunol, 2015; 194(9):4154–4161.
